Sopharma AD (3JR)

Profile

https://www.sopharmagroup.com

Sopharma AD is a leading Bulgarian pharmaceutical company established in 1933, specializing in the development, manufacturing, and marketing of over 200 human pharmaceutical products, including cardiovascular drugs, analgesics, vitamins, generic medications, plant-based substances, food supplements, veterinary products, and medical devices. As the parent entity of the Sopharma Group, it oversees a network of 14 pharmaceutical plants in Bulgaria, one in Ukraine, and two in Serbia, with production sites in Sofia, Sandanski, Vrabevo, Veliko Tarnovo, Kazanlak, and Sliven focusing on solid and liquid dosage forms, active pharmaceutical ingredients, and non-sterile products. The company conducts research and development, clinical trials, and regulatory registrations to address socially significant diseases, exporting to more than 40 countries, primarily in Eastern and Southeastern Europe such as Russia, Ukraine, Kazakhstan, and Poland. Through subsidiaries like Sopharma Trading AD, it engages in wholesale and retail distribution of pharmaceuticals, medical supplies, cosmetics, and logistics services across Bulgaria and Serbia. Headquartered in Sofia with approximately 6,099 employees, Sopharma AD plays a pivotal role in the healthcare sector by providing affordable, high-quality treatments compliant with European Good Manufacturing Practices standards.